Related Experiment Video
Updated: Jan 4, 2026

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
Published on: February 6, 2020
Establishing Institution-Specific Normative Data for the BREAST-Q Reconstruction Module: A Prospective Study
Kevin M Klifto1, Pathik Aravind1, Melissa Major1
1Department of Plastic and Reconstructive Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD.
Female breast satisfaction varies significantly by body mass index, age, race, and bra size. These factors influence patient-reported outcomes, establishing crucial baselines for breast research.
Area of Science:
- Plastic Surgery
- Patient-Reported Outcomes
- Health Disparities
Background:
- Breast satisfaction is understudied in general female populations.
- Existing research often lacks diverse community representation.
Purpose of the Study:
- Assess breast satisfaction using the BREAST-Q in a female cohort.
- Determine the influence of participant-related factors on breast satisfaction scores.
Main Methods:
- Prospective, single-center study of 300 females without breast cancer or surgery history.
- Utilized preoperative BREAST-Q reconstruction modules and demographic forms.
- Assessed factors like BMI, age, race, and bra cup size.
Main Results:
- Higher BMI correlated with lower Satisfaction with Breasts and Psychosocial Well-being.
- Older age linked to lower Sexual Well-being.
- African Americans reported higher satisfaction across multiple domains compared to Caucasians.
- Specific bra cup sizes (A, B, C) showed associations with higher scores in various well-being domains.
Conclusions:
- BMI, age, race, and bra size significantly impact BREAST-Q scores.
- Normative BREAST-Q scores can establish important baselines for breast outcomes research.
More Related Videos
10:42A Postoperative Evaluation Guideline for Computer-Assisted Reconstruction of the Mandible
Published on: January 28, 2020
03:07Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025